Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1734042 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL5987005 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL7099222 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL8031994 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL11807346 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL322318 | 1.00 | FDPS (0.36) | FDPSGGPS1MEN1KMT2ASMPD1 | |
| SCHEMBL15703706 | 0.98 | FDPS (0.35) | FDPSGGPS1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10907282 | 0.98 | FDPS (0.35) | FDPSGGPS1MEN1KMT2A | |
| SCHEMBL8076358 | 0.92 | ALDH1A1 (0.34) | — | |
| Glycinebetaine SCHEMBL3627272 | 0.85 | RAD52 (0.30) | FDPSGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |